Semaglutide is mostly effectively tolerated with identical dropout premiums when put next with placebo, even though it could be less properly tolerated than dulaglutide (Trulicity).one,3 The commonest adverse results are nausea, vomiting, and diarrhea and may be seasoned by about thirty% of patients, usually in the event the dose is improved.That�